{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T15:54:09Z","timestamp":1795276449402,"version":"4.10.3"},"reference-count":30,"publisher":"BMJ","issue":"8","funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"crossref","award":["K23 HL141448"],"award-info":[{"award-number":["K23 HL141448"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"crossref","award":["R01 HL158517"],"award-info":[{"award-number":["R01 HL158517"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2022,11,17]]},"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Fontan-associated liver disease (FALD) is universal post-Fontan palliation; however, its impact on survival remains controversial and current diagnostic tools have limitations. We aimed to assess the prognostic role of liver fibrosis scores (aminotransferase to platelet ratio [APRI] and fibrosis-4 [FIB-4]) and their association with haemodynamics and other markers of liver disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>159 adults (age \u226518 years) post-Fontan undergoing catheterisation at Mayo Clinic, Minnesota, between 1999 and 2017 were included. Invasive haemodynamics and FALD-related laboratory, imaging and pathology data were documented.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Mean age was 31.5\u00b19.3 years, while median age at Fontan procedure was 7.5 years (4\u201314). Median APRI score (n=159) was 0.49 (0.33\u20130.61) and median FIB-4 score (n=94) was 1.12 (0.71\u20131.65). Correlations between APRI and FIB-4 scores and Fontan pressures (r=0.30, p=0.0002; r=0.34, p=0.0008, respectively) and pulmonary arterial wedge pressure (r=0.25, p=0.002; r=0.30, p=0.005, respectively) were weak. Median average hepatic stiffness by magnetic resonance elastography was 4.9\u2009kPa (4.3\u20136.0; n=26) and 24 (77.4%) showed stage 3 or 4 liver fibrosis on biopsy; these variables were not associated with APRI\/FIB-4 scores. On multivariable analyses, APRI and FIB-4 scores were independently associated with overall mortality (HR 1.31 [1.07\u20131.55] per unit increase, p=0.003; HR 2.15 [1.31\u20133.54] per unit increase, p=0.003, respectively).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>APRI and FIB-4 scores were associated with long-term all-cause mortality in Fontan patients independent of other prognostic markers. Correlations between haemodynamic status and liver scores were weak; furthermore, most markers of liver fibrosis failed to correlate with non-invasive indices, underscoring the complexity of FALD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/heartjnl-2022-321435","type":"journal-article","created":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T13:25:33Z","timestamp":1672320333000},"page":"619-625","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":33,"title":["Haemodynamic and prognostic associations of liver fibrosis scores in Fontan-associated liver disease"],"prefix":"10.1136","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0889-1608","authenticated-orcid":false,"given":"Irene","family":"Martin de Miguel","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick S","family":"Kamath","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander C","family":"Egbe","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1116-8541","authenticated-orcid":false,"given":"C Charles","family":"Jain","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Cetta","sequence":"additional","affiliation":[{"name":"Division of Pediatric Cardiology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi M","family":"Connolly","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8864-8474","authenticated-orcid":false,"given":"William R","family":"Miranda","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,12,29]]},"reference":[{"key":"2025091922292990000_109.8.619.1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.26.3.240"},{"key":"2025091922292990000_109.8.619.2","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/ejhf.1365","article-title":"Haemodynamic profiles in adult Fontan patients: associated haemodynamics and prognosis","volume":"21","author":"Miranda","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2025091922292990000_109.8.619.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.07.065"},{"key":"2025091922292990000_109.8.619.4","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004809","article-title":"Hepatic fibrosis is universal following Fontan operation, and severity is associated with time from surgery: a liver biopsy and hemodynamic study","volume":"6","author":"Goldberg","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2025091922292990000_109.8.619.5","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/hep.32406","article-title":"Fontan\u2010associated liver disease","volume":"75","author":"Hilscher","year":"2022","journal-title":"Hepatology"},{"key":"2025091922292990000_109.8.619.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2015.11.014"},{"key":"2025091922292990000_109.8.619.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.10.045"},{"key":"2025091922292990000_109.8.619.8","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jtcvs.2016.10.060","article-title":"Liver health in adults with Fontan circulation: a multicenter cross-sectional study","volume":"153","author":"Wu","year":"2017","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025091922292990000_109.8.619.9","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.amjcard.2019.07.052","article-title":"Relation of magnetic resonance elastography to Fontan failure and portal hypertension","volume":"124","author":"Alsaied","year":"2019","journal-title":"Am J Cardiol"},{"key":"2025091922292990000_109.8.619.10","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14120","article-title":"Does liver biopsy accurately measure fibrosis in Fontan-associated liver disease? A comparison of liver biopsy pre-combined heart and liver transplant and liver explant post-transplant","volume":"34","author":"Vaikunth","year":"2020","journal-title":"Clin Transplant"},{"key":"2025091922292990000_109.8.619.11","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1161\/CIRCULATIONAHA.120.045597","article-title":"Fontan-associated liver disease: screening, management, and transplant considerations","volume":"142","author":"Emamaullee","year":"2020","journal-title":"Circulation"},{"key":"2025091922292990000_109.8.619.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2015.01.993"},{"key":"2025091922292990000_109.8.619.13","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50346"},{"key":"2025091922292990000_109.8.619.14","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21178"},{"key":"2025091922292990000_109.8.619.15","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24105"},{"key":"2025091922292990000_109.8.619.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2007.10.011"},{"key":"2025091922292990000_109.8.619.17","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-009-0046-6"},{"key":"2025091922292990000_109.8.619.18","doi-asserted-by":"crossref","first-page":"100362","DOI":"10.1016\/j.jhepr.2021.100362","article-title":"Non-invasive biomarkers of Fontan-associated liver disease","volume":"3","author":"Emamaullee","year":"2021","journal-title":"JHEP Rep"},{"key":"2025091922292990000_109.8.619.19","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s00246-020-02422-y","article-title":"Associated factors of liver disease after Fontan operation in relation to ultrasound liver elastography","volume":"41","author":"Sethasathien","year":"2020","journal-title":"Pediatr Cardiol"},{"key":"2025091922292990000_109.8.619.20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-200X.2011.03497.x"},{"key":"2025091922292990000_109.8.619.21","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijcard.2020.08.009","article-title":"Early development of hepatic fibrosis after Fontan procedure: a non-invasive study of a subclinical liver disease","volume":"320","author":"An","year":"2020","journal-title":"Int J Cardiol"},{"key":"2025091922292990000_109.8.619.22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S1665-2681(19)31807-1","article-title":"Use of AST platelet ratio index (APRI score) as an alternative to liver biopsy for treatment indication in chronic hepatitis C","volume":"8","author":"Borsoi Viana","year":"2009","journal-title":"Ann Hepatol"},{"key":"2025091922292990000_109.8.619.23","doi-asserted-by":"publisher","DOI":"10.1002\/lt.20906"},{"key":"2025091922292990000_109.8.619.24","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.mric.2014.05.001","article-title":"Magnetic resonance elastography of liver","volume":"22","author":"Venkatesh","year":"2014","journal-title":"Magn Reson Imaging Clin N Am"},{"key":"2025091922292990000_109.8.619.25","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1038\/modpathol.2014.79","article-title":"Congestive hepatic fibrosis score: a novel histologic assessment of clinical severity","volume":"27","author":"Dai","year":"2014","journal-title":"Mod Pathol"},{"key":"2025091922292990000_109.8.619.26","unstructured":"Accurint\u00ae . A LexisNexis\u00ae commercial location and research online service, 2005. LexisNexis. Available: http:\/\/www.accurint.com\/ [Accessed 13 Jan 2022]."},{"key":"2025091922292990000_109.8.619.27","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ijcard.2018.01.108","article-title":"Temporal changes in liver stiffness after Fontan operation: results of serial magnetic resonance elastography","volume":"258","author":"Egbe","year":"2018","journal-title":"Int J Cardiol"},{"key":"2025091922292990000_109.8.619.28","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/eurheartj\/ehy620","article-title":"The clinical spectrum of Fontan-associated liver disease: results from a prospective multimodality screening cohort","volume":"40","author":"Munsterman","year":"2019","journal-title":"Eur Heart J"},{"key":"2025091922292990000_109.8.619.29","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2011-301133"},{"key":"2025091922292990000_109.8.619.30","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2010.201772"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2022-321435","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T05:29:38Z","timestamp":1758346178000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2022-321435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,29]]},"references-count":30,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,3,27]]},"published-print":{"date-parts":[[2023,4]]}},"alternative-id":["10.1136\/heartjnl-2022-321435"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2022-321435","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,29]]}}}